Filter
12781
Filtered Results: 12781
Text search:
national
health
plan
Featured
Recommendations
987
New Publications
3381
Language
Document type
No document type
7147
Studies & Reports
2172
Guidelines
1600
Manuals
618
Strategic & Response Plan
495
Fact sheets
272
Training Material
212
Situation Updates
143
Resource Platforms
40
Infographics
32
Brochures
30
Online Courses
19
App
1
Countries / Regions
India
515
Global
474
Kenya
355
Ethiopia
259
Latin America and the Carribbean
250
Nepal
240
Nigeria
237
Sierra Leone
235
Uganda
232
South Africa
232
Liberia
208
Myanmar / Burma
195
Western and Central Europe
194
Congo, Democratic Republic of
184
Rwanda
179
Bangladesh
169
Senegal
168
Africa
166
Zambia
163
Malawi
163
Tanzania
157
Ghana
142
Indonesia
141
Syria
139
Brazil
129
Ukraine
122
Philippines
111
Haiti
106
Burkina Faso
105
Mozambique
105
Venezuela
95
Namibia
91
South Sudan
90
Guinea
89
Cambodia
88
Zimbabwe
82
Paraguay
81
Benin
80
Colombia
80
Lesotho
80
Eastern Europe
74
Germany
71
West and Central Africa
67
Cameroon
66
South–East Asia Region
65
Asia
61
Argentina
55
Yemen
53
East and Southern Africa
53
Madagascar
51
Russia
51
Botswana
50
Peru
49
Central African Republic
48
Middle East and North Africa
47
Pakistan
41
Afghanistan
41
Eswatini/ Swaziland
38
Mali
37
Chile
37
Ecuador
35
Eastern Europe and Central Asia
35
Angola
32
Bolivia
28
Somalia
27
Sudan
26
Lebanon
25
Niger
24
Jordan
24
Thailand
22
Western Pacific Region
22
Vietnam
22
Côte d’Ivoire / Ivory Coast
21
China
20
USA
19
Togo
19
Iraq
19
Tajikistan
18
Guinea-Bissau
17
Moldova
17
Sri Lanka
15
Turkey
14
Spain
14
Laos
13
Chad
12
El Salvador
12
Albania
12
Papua New Guinea
11
Libya
11
Mexico
11
Burundi
10
Palestine
10
Georgia
10
Egypt
9
Iran
9
North Macedonia
8
Honduras
8
Guatemala
8
Southern Africa
8
North America
8
Portugal
8
Morocco
7
Poland
7
Timor Leste/ East Timor
7
Romania
7
Kyrgyzstan
7
Jamaica
7
United Kingdom
7
Gambia
6
Nicaragua
6
Kazakhstan
6
Tunisia
6
Saudi Arabia
5
Malaysia
5
Dominican Republic
5
Switzerland
5
Hungary
5
Armenia
5
Turkmenistan
5
France
5
Mauritania
4
Serbia
4
Greece
4
Bhutan
4
Uruguay
4
Japan
4
Singapore
3
Vanuatu
3
Croatia
3
Fiji
3
Mongolia
3
Canada
3
Qatar
3
Estonia
3
Mauritius
3
Belarus
3
Israel
3
Bosnia and Herzegovina
3
Other region
2
North Korea
2
Italy
2
Djibouti
2
Congo-Brazzaville
2
Bulgaria
2
Lithuania
2
Slovakia
2
Uzbekistan
2
Gabon
2
Azerbaijan
2
Ireland
1
Austria
1
Cuba
1
Solomon Islands
1
Australia
1
Denmark
1
Belgium
1
Maldives
1
Norway
1
South Korea
1
Algeria
1
French Guyana
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
5359
Clinical Guidelines
799
Public Health
636
Women & Child Health
619
Key Resources
536
Capacity Building
217
Pharmacy & Technologies
119
Annual Report MEDBOX
1
Toolboxes
COVID-19
1207
Mental Health
899
HIV
858
TB
599
Planetary Health
516
Disability
469
Rapid Response
380
Ebola
359
AMR
355
Conflict
343
Caregiver
330
NTDs
239
Refugee
229
Global Health Education
221
Pharmacy
209
NCDs
194
Natural Hazards
174
Health Financing Toolbox
106
Zika
86
Polio
82
Cholera
75
Specific Hazards
73
Social Ethics
41
Typhoon
12
Health Financing
3
South Sudan
2
The ICOPE Implementation Framework provides a score card to help assess the overall capacity of health and social care services and systems to deliver integrated care in community settings and support the development of ICOPE implementation action <...s. There are 19 actions needed to implement ICOPE on the services level (meso) and systems level (macro). The scoring process provides an evidence-based means of highlighting areas for improvement as well as establishing concrete measures of future improvements
Progress in reducing tobacco use is a key indicator for measuring countries’ efforts to implement the WHO Framework Convention on Tobacco Control – target 3.a under the Sustainable Development Goals agenda. Countries have adopted this indicator to report progress also towards the tobacco reducti...
In May 2015, the Sixty-eighth World Health Assembly recognized the importance of the public health problem posed by antimicrobial resistance by adopting the global action ... on antimicrobial resistance (“global action plan”). The global action plan proposes interventions to control antimicrobial resistance, including reducing the unnecessary use of antimicrobials in humans and in animals. The global action plan also emphasizes the need to take a cross-sectoral, “One Health” approach for controlling antimicrobial resistance, involving efforts by actors from many disciplines including human and veterinary medicine.
The WHO Guidance for Conducting a Country COVID-19 Intra-Action Review (IAR) was developed to guide countries to conduct periodic review(s) of their national and subnational COVID-19 response, so countries do not miss critical opportunities for lear...
These guidelines group all recommendations on TB care and support in one document and are complemented by an operational handbook. The guidelines are to be used primarily by national TB programmes, or their equivalents in Ministries of ..., stakeholders and technical organizations working on TB care in the public and private sectors and in the community.
Available in Russian
A detailed overview is provided of the implementation of alcohol policies described in the 10 action areas of the European Action Plan to Reduce the Harmful Use of Alcohol 2012–2020 (EAPA), including the current status of imp...
УСПЕХИ В РЕАЛИЗАЦИИ ПОЛИТИКИ В ОТНОШЕНИИ КОНТРОЛЯ НАД АЛКОГОЛЬНОЙ ПРОДУКЦИЕЙ, 2010–2019 ГГ
A detailed overview is provided of the implementation of alcohol policies described in the 10 action areas of the European Action ... to Reduce the Harmful Use of Alcohol 2012–2020 (EAPA), including the current status of implementation of the five action areas of the WHO-led SAFER initiative:
Strengthen restrictions on alcohol availability;
Advance and enforce drink–driving countermeasures;
Facilitate access to screening, brief interventions and treatment;
Enforce bans or comprehensive restrictions on alcohol advertising, sponsorship and promotion; and
Raise prices on alcohol through excise taxes and pricing policies.
This manual describes methods for investigating clusters or outbreaks that may be of chemical origin and describes the importance of a structured, coordinated, collaborative multidisciplinary, multi-agency approach at local, regional, national and i...
The "Questions and Answers on Prevention and control of Alcohol related harm" has been developed by WHO country office in Viet Nam with technical contribution from national and international experts in the field. This publication provides scientific...
Since 1996, trachoma has been targeted for elimination as a public health problem worldwide. The active trachoma criterion for national elimination as a public ... problem is a TF1–9 < 5%, sustained for at least two years in the absence of antibiotic mass drug administration (MDA), in each formerly endemic EU. Using A, F and E, health ministries and their partners have made considerable progress towards achieving this criterion in formerly endemic EUs worldwide. In 2002, an estimated 1517 million people lived in EUs in which EU-wide implementation of the A, F and E components of SAFE were thought to be needed for the purposes of global elimination of trachoma as a public health problem; by June 2021, that number had fallen to 136.2 million, a 91% reduction. Approximately 85% of the 136.2 million people living in EUs needing A, F and E in June 2021 were in WHO’s African Region.
In January 2021, the World Health Organization (WHO) published a new road map to address the burden of disease and death imposed by neglected tropical diseases (NTDs). The end of the first year of the 2021-2030 NTD road map is an opportunity to take...
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la...
This document seeks to help health communication professionals working on the topic of immunization more effectively communicate about Events Supposedly Attributed to Vaccination and Immunization (ESAVI) by building trust in ... Immunization Programs, understanding risk perceptions related to vaccination, and responding to false information related to vaccination. It includes practical dos and don’ts regarding risk communication and community engagement processes and principles, messaging, risk perceptions, handling false information, collaborating with partners, and pharmacovigilance, as well as real-world examples.
This document provides a generic model that can be used for risk assessment of exposure to insecticide products applied as indoor residual sprays. It aims to harmonize the risk assessment of such insecticides for public health use in order to genera...
7 April 2021
The holy month of Ramadan (mid-April to mid-May 2021) is marked by social and religious gatherings. Because of the ongoing COVID-19 pandemic, it is imperative to observe the holiday with caution and care. This document provides up-to-date public ... advice that can be applied across different national contexts to make Ramadan-related activities safer.
14 de setembro de 2020Este Modelo de Valores fornece orientações globais para alocação de vacinas contra a COVID-19 entre os países, e orientações nacionais de priorização de grupos para vacinação dentro dos países em caso de oferta limitada. O Modelo destina-se a auxiliar os elaboradore...
El propósito de este marco de valores es brindar orientación a nivel mundial acerca de la asignación de las vacunas contra la COVID-19 entre los países y a nivel nacional con respecto a la determinación de los grupos prioritarios para recibirla...
Licensed pharmaceutical products (marketing authorization) should be manufactured only by licensed manufacturers (holders of a manufacturing authorization) whose activities are regularly inspected by competent national authorities. This guide to GMP...
In the context of the coronavirus disease (COVID-19) pandemic response, WHO identifies young people as a priority target audience with specific concerns, experiences and behaviours. This policy brief provides relevant insights from behavioural evidence and a set of behavioural considerations for tho...
Pharmaceutical regulators are at the forefront of ensuring that only safe and effective medicines are authorized and available in the market. This document builds on the recommendations in the above publication and has been prepared to specifically assist ... medicines regulatory authorities to understand the nature and extent of oxytocin quality issues and to provide key technical information and quality requirements for oxytocin products in dossier assessments. Furthermore, this document also presents recommendations on other regulatory actions needed to ensure that only quality-assured oxytocin products are authorized and made available to women.
